映恩生物两项研究结果将在2025美国临床肿瘤学会年会公布

氨基观察
24 Apr

2025年美国临床肿瘤学会(ASCO)年会将于5月30日至6月3日在美国芝加哥举行。映恩生物(9606.HK)将在以口头报告形式公布HER3 ADC DB-1310及B7H3 ADC DB-1311/BNT324的两项研究结果,相关研究摘要全文将于当地时间 2025年5月23日发布在 ASCO 官方网站上。HER3 ADC DB-1310:· 标题:DB-1310(HER3靶向抗体偶联药物)用于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10